Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Diabetes Treatment and Management
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the management of diabetes mellitus, with a particular emphasis on cardiovascular outcomes, glucose control, and the use of incretin hormones, SGLT2 inhibitors, and dipeptidyl peptidase-4 inhibitors. It also covers topics such as heart failure, glycemic control, insulin therapy, and clinical guidelines for the treatment of type 2 diabetes.
1,233
Works
IDs:OpenAlex
How has Diabetes Treatment and Management's publication output changed over time?
ScholarIQpublication output · 2003–2021
Output grew100% over the shown period — from 1 works in 2003 to 2 in 2021.
1
2
1
1
2
1
1
2
2
2
2003200820122015201620172018201920202021
What are the most-cited papers on Diabetes Treatment and Management?
ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R. Matthews
New England Journal of Medicine. 20177,831 CitationsOPEN ACCESS
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews, H. A. W. Neil
New England Journal of Medicine. 20087,788 CitationsOPEN ACCESS
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen, Peter Lommer Kristensen, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock, Neil R Poulter, Lasse Steen Ravn, William M. Steinberg, Mette Stockner, Bernard Zinman, Richard M. Bergenstal, John B. Buse
New England Journal of Medicine. 20167,491 CitationsOPEN ACCESS
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
New England Journal of Medicine. 20087,445 CitationsOPEN ACCESS
Where is Diabetes Treatment and Management research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
Diabetologia3,934
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Diabetes Treatment and Management is open access?
ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
0%
Bronze
93%
Closed
0%
Related on ScholarIQ
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Paper
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Paper
Effects of Intensive Glucose Lowering in Type 2 Diabetes
Paper
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Paper
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Paper
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Paper